ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,335.81
-0.28%
Dow Jones
44,954.37
0.56%
Gold vs US Dollar
2,652.47
0.37%
Brent Oil
72.405
-1.63%
Bitcoin
96,999.99
1.07%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. I MAB (IMAB)

  7. I MAB (IMAB) News

I MAB (IMAB)

I MAB
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMAB
DateTimeSourceHeadlineSymbolCompany
21/11/202412:00PR Newswire (US)I-Mab to Participate at the Piper Sandler Healthcare ConferenceNASDAQ:IMABI MAB
14/11/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
14/11/202412:00PR Newswire (US)I-Mab Reports Third Quarter 2024 ResultsNASDAQ:IMABI MAB
06/11/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
06/11/202412:00PR Newswire (US)I-Mab Appoints Sean Fu, PhD, MBA, as Chief Executive OfficerNASDAQ:IMABI MAB
05/11/202421:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
31/10/202411:00PR Newswire (US)I-Mab to Release Q3 2024 Financial Results on November 14, 2024NASDAQ:IMABI MAB
30/10/202411:00PR Newswire (US)I-Mab to Present Givastomig Phase 1 Optimal Dose Estimation Data at SITC 2024NASDAQ:IMABI MAB
28/10/202411:00PR Newswire (US)I-Mab to Participate at the Truist Securities BioPharma SymposiumNASDAQ:IMABI MAB
24/10/202411:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
23/09/202411:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
16/09/202420:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
16/09/202420:01PR Newswire (US)I-Mab Presents Updated Phase 1 Givastomig Data at ESMO 2024NASDAQ:IMABI MAB
10/09/202411:00PR Newswire (US)I-Mab Presents Positive Uliledlimab Pharmacokinetics Data at 2024 World Conference on Lung CancerNASDAQ:IMABI MAB
30/08/202419:23Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
28/08/202411:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
28/08/202411:00PR Newswire (US)I-Mab Reports 1H 2024 Financial Results, Pipeline Progress, and Business UpdatesNASDAQ:IMABI MAB
26/08/202411:00PR Newswire (US)I-Mab to Participate at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:IMABI MAB
14/08/202411:00PR Newswire (US)I-Mab to Release 1H 2024 Financial Results on August 28, 2024NASDAQ:IMABI MAB
07/08/202411:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
07/08/202411:00PR Newswire (US)I-Mab Appoints U.S. Auditor, PricewaterhouseCoopers LLP (PwC)NASDAQ:IMABI MAB
26/07/202410:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
17/07/202410:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IMABI MAB
15/07/202411:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
15/07/202411:30PR Newswire (US)I-Mab Announces Leadership TransitionsNASDAQ:IMABI MAB
06/06/202411:14Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
06/06/202411:00PR Newswire (US)I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical OfficerNASDAQ:IMABI MAB
05/06/202411:11Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:IMABI MAB
05/06/202411:00PR Newswire (US)I-Mab Announces Collaboration with Bristol Myers Squibb to Evaluate Givastomig in a Combination Study for Newly Diagnosed Gastric and Esophageal CancersNASDAQ:IMABI MAB
30/05/202421:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:IMABI MAB
 Showing the most relevant articles for your search:NASDAQ:IMAB

Your Recent History

NASDAQI
DWCSTR
Dorsey Wright Consumer S...
BIT
P1QJK7
BNP Paribas Issuance
NASDAQI
INWNTR
Horizon Kinetics ISE Int...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved